TY  - JOUR 
AU  - Roccaro, Aldo M
AU  - Sacco, Antonio
AU  - Jiménez, Cristina
AU  - Maiso, Patricia
AU  - Moschetta, Michele
AU  - Mishima, Yuji
AU  - Aljawai, Yosra
AU  - Sahin, Ilyas
AU  - Kuhne, Michelle
AU  - Cardarelli, Pina
AU  - Cohen, Lewis
AU  - San Miguel Izquierdo, Jesús Fernando
AU  - García Sanz, Ramón
AU  - Ghobrial, Irene M
PY  - 2014
SN  - 0006-4971
UR  - http://hdl.handle.net/10366/155409
AB  - [EN]The C-X-C chemokine receptor type 4 (CXCR4) plays a crucial role in modulating cell trafficking in hematopoietic stem cells and clonal B cells. We screened 418 patients with B-cell lymphoproliferative disorders and described the presence of the...
LA  - eng
PB  - American Society of Hematology
KW  - Waldenstrom macrogobulinemia
KW  - Management
KW  - Treatment
KW  - C1013G/CXCR4
KW  - Disease-Free Survival
KW  - Transplantation
KW  - Boronic Acids
KW  - Heterografts
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Pyrazines
KW  - Drug Therapy
KW  - Cell Proliferation
KW  - Waldenstrom Macroglobulinemia
KW  - Neoplasm Transplantation
KW  - Drug Resistance
KW  - Enzyme Inhibitors
KW  - Mutation
KW  - Neoplasm Metastasis
KW  - Antibodies
KW  - Thalidomide
KW  - Animals
KW  - Survival Rate
KW  - Mice
TI  - C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma
DO  - 10.1182/blood-2014-03-564583
T2  - Blood
VL  - 123
M2  - 4120
ER  -